President Donald Trump just dropped a bombshell on Big Pharma’s bloated profits. On Monday, he signed a “most-favored nation” executive order to slash prescription drug prices, claiming Americans will soon pay the lowest prices worldwide. It’s a bold move that’s got pharmaceutical giants sweating and woke bureaucrats clutching their pearls, Fox Business reported.
Trump’s order aims to align U.S. drug prices with the cheapest global rates, targeting the absurd reality where Americans pay up to ten times more for the same medications. The administration also wants to boost domestic drug manufacturing and kneecap the shady middlemen—pharmacy benefit managers—who’ve been fleecing consumers for years.
“The United States will no longer subsidize the health care of foreign countries,” Trump declared. Well, about time someone called out the global freeloader system. For too long, Americans have bankrolled Big Pharma’s profits while other nations skate by on the cheap.
Trump’s not mincing words, claiming some drug prices could plummet by 50% to 90% almost immediately. On Truth Social, he posted Sunday that cuts of 30% to 80% are coming fast. No specifics yet, but the man’s got a knack for shaking things up, so let’s see if the follow-through matches the hype.
Pharmaceutical companies, which rake in over two-thirds of their profits from the U.S. despite our small population share, now face a choice: comply voluntarily or deal with federal muscle. Actions have consequences, and Big Pharma’s days of price gouging might just be numbered.
“We are going to pay the lowest price there is in the world,” Trump vowed. That’s the kind of promise that makes sense to anyone who’s ever choked on a pharmacy bill. But the devil’s in the details, and the administration’s keeping those cards close for now.
The executive order also takes aim at pharmacy benefit managers, the so-called “middlemen” who negotiate prices and control access to meds. These shadowy operators drive up costs, jack up out-of-pocket expenses, and even force rural pharmacies to shutter. Good riddance to a system that’s been ripping off the little guy for far too long.
In 2022, U.S. drug prices were nearly 2.8 times higher than in other countries, with brand-name drugs costing at least 3.2 times more. That’s not just a statistic—it’s a scandal. Trump’s order is a direct shot at this insanity, demanding fairness for American wallets.
“Some prescription drug prices will be reduced almost immediately by 50 to 80 to 90%,” Trump boasted. If he pulls that off, it’ll be a game-changer for millions struggling with healthcare costs. But the woke elite will probably cry “unfair” while sipping their overpriced lattes.
Over the next month, Dr. Mehmet Oz, head of the Centers for Medicare and Medicaid Services, will team up with Trump and Health and Human Services Secretary Robert F. Kennedy Jr. to hammer out the details with pharma execs. Oz says the nation will still lead in curing diseases like cancer. Nice to know we can save lives without bankrupting families.
“The nation will still be curing cancer and a slew of other ailments,” Oz assured. That’s a relief, because the last thing we need is Big Pharma’s sob story about innovation drying up. Maybe they can innovate their way to fair pricing for once.
Oz also hinted at a “thoughtful interaction” with pharma leaders, many of whom he claims privately agree the system’s broken. “They’re patriotic Americans,” he said. Sure, but let’s see if their patriotism extends to their profit margins.
The U.S. spends a growing chunk of its drug budget on new medications compared to other countries, and consumers are getting hammered by restrictive insurance plans. It’s a rigged game, and Trump’s order is a long-overdue attempt to level the playing field. No more subsidizing the world while Americans drown in medical debt.
“The rest of the world is going to have to pay a little bit more, and America is going to pay a lot less,” Trump said. Equalizing, he calls it, and it’s hard to argue with that logic. Why should we keep footing the bill for everyone else’s cheap drugs?
Trump’s plan might just force Big Pharma to rethink its greedy playbook, and that’s a win for every American tired of being fleeced. The road ahead won’t be easy—woke regulators and corporate cronies will fight tooth and nail. But if this order delivers, it’ll prove that common sense can still win in Washington.
